Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NTLA
Stock Latest News
Market News
Cathie Wood Keeps Loading Up on This Biotech Stock — What’s Driving the Buying Spree?
4h ago
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment buys 40K shares of Intellia Therapeutics today
17h ago
NTLA
Premium
Market News
Cathie Wood Doubles Down on High-Potential Biotech Plays
24h ago
TER
TXG
Premium
Market News
NTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina
2d ago
ILMN
NTLA
Premium
Weekend Updates
Synopsys, Reddit, Intellia, Symbotic, Seagate Insider Shock
4d ago
STX
SYM
Premium
Ratings
Balancing Promise and Uncertainty: Justifying a Hold on Intellia Ahead of Key Late‑Stage Readouts
5d ago
NTLA
Premium
Company Announcements
Intellia Updates Investors on Nex-Z Trial Safety Hold
5d ago
8K
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $12 from $14 at BofA
8d ago
NTLA
Premium
Market News
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
14d ago
BEAM
IONS
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
2M ago
BNTC
CRSP
Premium
Weekend Updates
Algonquin, Spotify, Keysight, Intellia, CoreWeave: Trending by Analysts
2M ago
AQN
CRWV
Premium
Company Announcements
Intellia Therapeutics Reports Q3 2025 Financial Results
2M ago
NTLA
Premium
The Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
2M ago
C
T
Premium
The Fly
Carvana initiated, AT&T upgraded: Wall Street’s top analyst calls
2M ago
T
AN
Premium
The Fly
Wolfe downgrades Intellia to Peer Perform on Nex-z safety issue
2M ago
NTLA
Premium
The Fly
Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
2M ago
NTLA
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
2M ago
AZN
BMY
Premium
The Fly
Intellia Therapeutics downgraded to Hold from Buy at JonesResearch
2M ago
NTLA
Premium
The Fly
Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI
2M ago
NTLA
Premium
Company Announcements
Intellia Reports Favorable Phase 1 Data for Nex-Z
2M ago
8K
NTLA
Premium
The Fly
Intellia announces ‘positive’ follow-up data from ongoing Phase 1 nex-z trial
2M ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $14 from $25 at Truist
2M ago
NTLA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
